Stockreport

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a dif [Read more]